Smoking cessation
Smoking cessation positively impacts all 5 clinical areas identified by Core20PLUS5 adults.
Use the dropdowns on this page to see NICE guidance mapped to the main aim for this clinical area.
Tobacco: preventing uptake, promoting quitting and treating dependence (NG209) covers support to stop smoking for everyone aged 12 and over, and help to reduce people's harm from smoking if they are not ready to stop in one go.
Cardiovascular disease: identifying and supporting people most at risk of dying early (PH15) aims to reduce the number of people who are disadvantaged, dying prematurely by ensuring people have better access to flexible, well-coordinated treatment and support.
Tobacco: treating dependence (QS207) covers support and treatment to stop smoking and stop using smokeless tobacco, and harm-reduction approaches for people who are not ready to stop in one go. It describes high-quality care in priority areas for improvement.
Tools to help put our guidance into practice
Tobacco: treating dependence (QS207) Quality standard service improvement template facilitates an initial assessment of current service provision compared with a selection of quality statements; recording of an action plan and monitoring quality improvement over time.
Further resources
View our recommendations for research on Tobacco: preventing uptake, promoting quitting and treating dependence.